RUPP RANDALL 4
4 · REGENERON PHARMACEUTICALS INC · Filed Jan 9, 2006
Insider Transaction Report
Form 4
RUPP RANDALL
SVP, Manuf & Process Sciences
Transactions
- Sale
Common Stock
2006-01-05$15.80/sh−4,000$63,200→ 7,957 total - Sale
Common Stock
2006-01-09$16.88/sh−1,682$28,392→ 6,275 total
Footnotes (1)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).